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The magnocellular pathway and schizophreniaqI read with great interest the recent review of Skottun
and Skoyles (2007) on contrast sensitivity and magnocellu-
lar functions in schizophrenia. The authors critically re-
viewed available contrast sensitivity studies and
concluded that these data do not provide evidence for the
existence of an association between magnocellular deﬁcits
and schizophrenia. The main criticism was related to the
fact that contrast sensitivity loss is not conﬁned to low spa-
tial frequencies in schizophrenia. Instead, the majority of
studies found generalized contrast sensitivity loss, which
can be explained by attention dysfunctions. The authors
also claimed that contrast sensitivity data do not indicate
the overactivity of magnocellular pathways or the detri-
mental eﬀect of antipsychotic medications. Although I
agree with the authors that further investigations are neces-
sary, I think that the basic conclusion of the review is not
entirely correct. If we want to make conclusions about
the functioning of magnocellular and parvocellular path-
ways in schizophrenia, it is not suﬃcient to focus on lumi-
nance contrast sensitivity data. Instead, a more
comprehensive and integrative review of results from
behavioral, electrophysiological, and brain imaging studies
is necessary, as done by Butler and Javitt (2005). These
data indicate a predominant magnocellular dysfunction,
with some additional deﬁcits of the parvocellular pathways
in schizophrenia. These dysfunctions are associated with
structural changes of the occipital cortex and the optic
radiation (Butler & Javitt, 2005). Here, I will focus on four
critical questions which are closely related to the review of
Skottun and Skoyles.
First, the authors overemphasized the role of spatial fre-
quency in the assessment of magnocellular versus parvocel-
lular contributions to contrast sensitivity. Although there is
a general consensus that magnocellular pathways are opti-
mally activated by stimuli with low contrast and low spatial
frequency, it has been shown that oﬀ-center magnocellular
units display higher contrast sensitivity than parvocellular
units even at 9 cycles/degree (Hicks, Lee, & Vidyasagar,0042-6989/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
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2923–2933.1983). Kaplan, Purpura, and Shapley (1987) demonstrated
that the transmission ratio of the lateral geniculate nucleus
(geniculate response/retinal response) depend on stimulus
contrast (non-linear contrast gain control) and temporal
frequency. However, the attenuating eﬀect of the lateral
geniculate nucleus was less aﬀected by the spatial frequency
of the stimulus. With the integration of animal physiolog-
ical and human psychophysical observations, Plainis and
Murray (2000) concluded that the magnocellular system
is the physiological substrate for most of the contrast sen-
sitivity functions, with the exception of the highest spatial
frequencies. Skottun and Skoyles stated that the parvocel-
lular system carries out contrast detection above 1.5 cycles/
degree. This estimation may not be correct; magnocellular
pathways may be important at higher spatial frequencies.
Given the contrast gain characteristics of parvocellular
pathways, low contrast gratings even at higher spatial fre-
quencies are not optimal to isolate these pathways. Neuro-
physiological and lesion studies in primates suggest that
chromatic stimulus properties can more optimally isolate
magnocellular and parvocellular visual pathways than spa-
tial stimulus properties alone (Lee, 1996). This assumption
is supported by human studies demonstrating that the
degeneration of the magnocellular pathways in fragile X
syndrome does not disrupt chromatic contrast sensitivity
(Kogan et al., 2004).
To more parsimoniously isolate magnocellular and par-
vocellular pathways, we used a spatial oﬀset detection (ver-
nier) task during which stimuli were low contrast (5%)
dots, frequency-doubling gratings (25 Hz), and dots de-
ﬁned by hue (isoluminant color) (Ke´ri, Kelemen, Benedek,
& Janka, 2004, 2005). Achromatic vernier acuity may be
preserved after the lesion of the parvocellular system
(Lynch, Silveira, Perry, & Merigan, 1992), and there is a
strong correspondence between the electrophysiological re-
sponses of primate magnocellular ganglion cells and hu-
man psychophysical performance when low contrast
vernier stimuli are used (Lee, Wehrhahn, Westheimer, &
Kremers, 1995; Sun, Ru¨ttiger, & Lee, 2004). This is true
even during foveal viewing (Wehrhahn & Westheimer,
1990). In contrast, the isoluminant color condition biases
information processing towards the parvocellular pathways.
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cated and medicated schizophrenia patients as well as their
biological relatives consistently showed more deﬁnitive
impairments in the low contrast and frequency-doubling
conditions than in the isoluminant condition which is a
very likely indicator of magnocellular dysfunction. These
results are not properly interpreted by Skottun and Skoy-
les, amalgamating these results with the contrast sensitivity
data. In addition, the diﬀerential deﬁcit found in the ver-
nier tasks is against the possibility that early visual impair-
ments can fully be explained by a generalized attention
deﬁcit, as claimed by Skottun and Skoyles.
Third, regarding the eﬀect of antipsychotic medications,
Skottun and Skoyles did not take into consideration the
diﬀerent characteristics of typical (ﬁrst-generation) and
atypical (second-generation) antipsychotics. Typical drugs
strongly block D2 dopamine receptors leading to ‘‘visual
Parkinsonism”, whereas atypical drugs with weaker dopa-
mine receptor inhibiting properties and additional pharma-
cological actions (e.g., blockade of the 5-HT2A serotonin
receptors) do not do so. Therefore, it is important to take
into consideration earlier studies that were conducted be-
fore the era of atypical antipsychotics. These studies sug-
gest a detrimental eﬀect of antipsychotics on contrast
sensitivity functions (e.g., Bulens, Meerwaldt, van der
Wildt, & Keemink, 1989). In contrast, atypical drugs do
not disrupt contrast sensitivity (Chen et al., 2003).
Fourth, when arguing against the overactivity of mag-
nocellular pathways, Skottun and Skoyles did not take into
consideration the possibility that magnocellular dysfunc-
tions may change during the course of the illness. Recently,
using a steady- and pulsed-pedestal paradigm, we showed
that persons at a very early (prodromal) stage of the illness
display elevated contrast sensitivity during a magnocellular
test and normal sensitivity during a parvocellular test.
Chen et al. (2003) also found that unmedicated schizophre-
nia patients show higher contrast sensitivity (lower thresh-
old) as compared with that of the controls. The severity of
visual illusions experiences by the prodromal participants
positively correlated with the magnocellular sensitivity val-
ues (Ke´ri & Benedek, 2007). These results suggest that the
early active stage of the illness is associated with overactive
magnocellular pathways, which may be responsible for the
experience of abnormal intensity of environmental stimuli,
feelings of being ﬂooded and inundated, and inability to fo-
cus attention to relevant details.
In summary, the review of Skottun and Skoyles did not
integrate data from new behavioral paradigms and from a
number of electrophysiological and brain imaging studies
which all suggest the marked impairment of magnocellular
pathways in schizophrenia (Butler & Javitt, 2005). A more
balanced review and discussion would be necessary to seethe real picture which may help researchers ﬁnd the most
critical issues for future studies.
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